My Cart [ 0 ]
New Products
New Services
Promotions
News
Home > Research-Grade Biosimilars
Recombinant research-grade biosimilars (RUO) have the same protein sequences of therapeutic grade biologics (proteins and antibodies) with lower prices (starting from $30/mg for bulk order). For research use only.
    70 Research-Grade Biosimilars Products
  • C034P: Secukinumab Biosimilar, Human IL17A Monoclonal Antibody

    Recombinant fully human IgG1 monoclonal antibody.
    Specificity/Sensitivity: The monoclonal antibody Secukinumab biosimilar specifically binds to the human IL17A.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by Secukinumab.

  • C062P: Relatlimab Biosimilar, Human LAG-3 Monoclonal Antibody

    Recombinant Humanized IgG4 Monoclonal Antibody.
    Specificity/Sensitivity: The research grade relatlimab biosimilar specifically binds to the human lymphocyte-activation gene 3 (LAG-3).
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by relatlimab.

  • C005P: Ranibizumab Biosimilar, Human VEGF Monoclonal Antibody Fragment (Fab)

    Recombinant Humanized Monoclonal Antibody Fragment (Fab) generated from the same parent mouse antibody as bevacizumab.
    Specificity/Sensitivity: The research grade Fab protein ranibizumab specifically binds to the human VEGF-A.
    Applications: Functional assay, neutralization.

  • C061P: Ramucirumab Biosimilar, Human VEGFR2 Monoclonal Antibody

    Recombinant Human IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The monoclonal antibody ramucirumab biosimilar specifically binds to the human VEGFR2 (KDR).
    Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by ramucirumab.

  • C006P: Pertuzumab Biosimilar, Human HER2 Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The monoclonal antibody pertuzumab biosimilar specifically binds to the human HER2/ErbB-2/c-neu.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by pertuzumab.

  • C012P: Panitumumab Biosimilar, Human EGFR/ErbB-1/HER1 Monoclonal Antibody

    Recombinant Humanized IgG2 Monoclonal Antibody.
    Specificity/Sensitivity: The monoclonal antibody panitumumab biosimilar specifically binds to the human EGFR, ErbB-1 and HER1.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by panitumumab.

  • C021P: Palivizumab Biosimilar, RSV Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The monoclonal antibody palivizumab biosimilar specifically binds to an epitope in the A antigenic site of the F protein of RSV (respiratory syncytial virus).
    Applications: ELISA, neutralization, functional assays.

  • C020P: Omalizumab Biosimilar, Human IgE Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The monoclonal antibody Omalizumab specifically binds to the human immunoglobulin E (IgE) free in the blood and interstitial fluid and to membrane-bound form of IgE (mIgE) on the surface of mIgE-expressing B lymphocytes. It does not bind to IgE that is already bound by the high affinity IgE receptor (FcεRI) on the surface of mast cells, basophils, and antigen-presenting dendritic cells.
    Applications: Functional assay, neutralization, blocking, ELISA.

  • C057P: Obinutuzumab Biosimilar, CD20 Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade obinutuzumab biosimilar specifically binds to the human type II CD20 antibodies.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by obinutuzumab.

  • C050P: Ipilimumab Biosimilar, CTLA-4 Monoclonal Antibody

    Recombinant Humanized IgG1 Monoclonal Antibody.
    Specificity/Sensitivity: The in vivo grade ipilimumab biosimilar specifically binds to the human CTLA4.
    Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by ipilimumab.

See our Privacy Policy